ALEXANDRIA, Va., March 12 -- United States Patent no. 12,247,978, issued on March 11, was assigned to Arizona Board of Regents on behalf of Northern Arizona University (Flagstaff, Ariz.).

"Compositions and methods for detection and treatment of coronavirus infection" was invented by John Altin (Flagstaff, Ariz.) and Jason Ladner (Flagstaff, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure includes a multiplexed peptide assay to generate an epitope-resolved view of antibody reactivity across all human coronaviruses (CoVs). PepSeq accurately classifies SARS-CoV-2 exposure status and reveals epitopes across the Spike and Nucleocapsid proteins. Two of these represent recurrent reactivi...